C

California Research Foundation | San Diego, CA

Research site

(Unclaimed)

Location

9444 Farnham Street Suite #200, San Diego, California, United States of America

Site insights

Top conditions

Top treatments

Tanezumab

Bococizumab

Lasmiditan

rLP2086

Fesoterodine

Atogepant

Semaglutide

Naproxen

Ibuprofen

Metformin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 77 total trials

Efficacy and Safety of NVX-CoV2705 (COVID-19)

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19 vaccine. Approx...

Active, not recruiting

COVID-19

Sars-CoV-2 Infection

Biological: NVX-CoV2705

Biological: Placebo

Study of DONQ52 in Active Celiac Disease

The main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants...

Enrolling

Celiac Disease

Dietary Supplement: Simulated Inadvertent Gluten Exposure (SIGE) capsule

Drug: DONQ52

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidat...

Enrolling

Acne

Other: Placebo

Biological: Acne mRNA vaccine

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. (RENOIR)

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting

Lower Respiratory Tract Illness

Biological: RSVpreF

Biological: Placebo